Novacept
Palo Alto, California, United States
About Novacept
Novacept was founded in 1995 to design, develop, manufacture and market innovative therapeutic devices to improve the quality of women's healthcare in a cost-effective manner. Developed by Novacept, the NovaSure Impedance Controlled Endometrial Ablation System is a next generation medical device designed to reduce or eliminate excessive menstrual bleeding due to benign causes in pre-menopausal women who have completed childbearing.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $30.0M
- Funding stage: M&A
- Last round: Series Unknown (Mar 2002)
- Website: novacept.com
- Phone: +1 (650) 335-2711
Industries & Categories
Health Care, Manufacturing, Medical
Canonical: https://fsome.com/organization/novacept-2563558 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.